Shanghai ZJ Bio-Tech Co Ltd Class A 688317
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 16.08
- Day Range
- CNY 16.12–16.45
- 52-Week Range
- CNY 12.58–28.32
- Bid/Ask
- CNY 16.42 / CNY 16.43
- Market Cap
- CNY 3.20 Bil
- Volume/Avg
- 2.6 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 43.83
- Price/Sales
- 12.70
- Dividend Yield (Trailing)
- 7.46%
- Dividend Yield (Forward)
- 7.46%
- Total Yield
- 7.46%
Company Profile
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 435
- Website
- https://www.liferiver.com.cn
Comparables
Valuation
|
Metric
|
688317
|
300482
|
688468
|
|---|---|---|---|
Price/Earnings (Normalized) | 43.83 | 26.92 | 21.13 |
Price/Book Value | 0.82 | 2.41 | 2.15 |
Price/Sales | 12.70 | 4.40 | 6.48 |
Price/Cash Flow | 28.84 | 18.51 | 15.34 |
Price/Earnings
688317
300482
688468
Financial Strength
|
Metric
|
688317
|
300482
|
688468
|
|---|---|---|---|
Quick Ratio | 14.78 | 6.55 | 4.92 |
Current Ratio | 16.22 | 8.89 | 5.69 |
Interest Coverage | −519.01 | 19.42 | 243.98 |
Quick Ratio
688317
300482
688468
Profitability
|
Metric
|
688317
|
300482
|
688468
|
|---|---|---|---|
Return on Assets (Normalized) | −3.23% | 4.38% | 8.96% |
Return on Equity (Normalized) | −3.43% | 5.88% | 11.16% |
Return on Invested Capital (Normalized) | −4.54% | 5.54% | 9.70% |
Return on Assets
688317
300482
688468
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Sybqhvdn | Lnfxzqj | $184.2 Bil | |
SYK
| Stryker Corp | Xrgsghtlxt | Lnk | $125.1 Bil | |
MDT
| Medtronic PLC | Cgtfhrj | Yhjypjs | $108.5 Bil | |
BSX
| Boston Scientific Corp | Jmlhbvvk | Ksrgk | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Tyzvkxrlj | Pgyycp | $51.4 Bil | |
DXCM
| DexCom Inc | Lmgkrbdy | Sllzd | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Gmmyhqwkzb | Yfb | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Rllsdlpyl | Vvkbj | $24.4 Bil | |
ALGN
| Align Technology Inc | Rmqbhzv | Hmgxms | $21.7 Bil | |
PODD
| Insulet Corp | Vqsbslwbt | Fsrwh | $12.2 Bil |